SRS — A Focused Approach
The SRS market is growing rapidly, fueled by strong reimbursement, physician adoption, patient demand, and better clinical outcomes. Increasingly SRS provides an effective treatment alternative for an increasingly wide range of specialties in both cancer care and the neurosciences, including:
- Neurosurgery
- Radiation Oncology
- Surgical Oncology
- Pulmonology
- Urology
- Neurology
- ENT
- General Surgery
- Thoracic Surgery
With a projected growth rate of more than 363% in the next few years, the time to take advantage of this opportunity is now.
Accelitech is the industry leader in creating a joint venture to secure SRS technology and develop cutting-edge SRS programs. To read more about the significant opportunity for growth in SRS, click here.
Early radiosurgery applications were primarily for the treatment of brain tumors; however, rapid advances in technology have resulted in continued growth and opportunity in extracranial radiosurgery. To read more, click here.